Results 261 to 270 of about 401,950 (315)

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić   +7 more
wiley   +1 more source

Skeletal muscle-kidney crosstalk in a cohort of critical illness survivors. [PDF]

open access: yesPLoS One
Ribeiro HS   +11 more
europepmc   +1 more source

Non-small Cell Lung Cancer in Women: Experience From the National Institute of Oncology, Rabat, Morocco. [PDF]

open access: yesCureus
Cherkaoui B   +6 more
europepmc   +1 more source

Establishment of a Flow Cytometry Protocol for Binarily Detecting Circulating Tumor Cells with EGFR Mutation. [PDF]

open access: yesDiseases
Chang CY   +11 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy